API INNOVATION CENTER Trademark

Trademark Overview

On Thursday, April 27, 2023, a trademark application was filed for API INNOVATION CENTER with the United States Patent and Trademark Office. The USPTO has given the API INNOVATION CENTER trademark a serial number of 97909830. The federal status of this trademark filing is REGISTERED as of Tuesday, February 4, 2025. This trademark is owned by API Innovation Center. The API INNOVATION CENTER trademark is filed in the Advertising, Business and Retail Services category with the following description:

Promoting collaboration within the scientific, research, and medical communities to achieve advances in the field of the production of pharmaceuticals, medicines, and drugs
api innovation center

General Information

Serial Number97909830
Word MarkAPI INNOVATION CENTER
Filing DateThursday, April 27, 2023
Status700 - REGISTERED
Status DateTuesday, February 4, 2025
Registration Number7674961
Registration DateTuesday, February 4, 2025
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements

Description of MarkThe mark consists of the stacked wording "API INNOVATION CENTER" centered in a circular design.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPromoting collaboration within the scientific, research, and medical communities to achieve advances in the field of the production of pharmaceuticals, medicines, and drugs
NOT AVAILABLE"API INNOVATION CENTER"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 25, 2023
Primary Code035
First Use Anywhere DateWednesday, October 6, 2021
First Use In Commerce DateWednesday, October 6, 2021

Trademark Owner History

Party NameAPI Innovation Center
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSt. Louis, MO 63108
Party NameAPI Innovation Center
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSt. Louis, MO 63108
Party NameAPI Innovation Center
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSt. Louis, MO 63108

Trademark Events

Event DateEvent Description
Monday, May 1, 2023NEW APPLICATION ENTERED
Friday, May 26, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 4, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 4, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 24, 2024ASSIGNED TO EXAMINER
Friday, April 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 26, 2024NON-FINAL ACTION WRITTEN
Friday, January 26, 2024NON-FINAL ACTION E-MAILED
Friday, January 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 21, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, November 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 21, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, November 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, February 4, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 21, 2024FINAL REFUSAL WRITTEN
Tuesday, May 21, 2024FINAL REFUSAL E-MAILED
Tuesday, May 21, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 21, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords

center innovation field advances production pharmaceuticals drugs medicines achieve communities within collaboration